SOLIGENIX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4045 USD | 0.00% |
|
-2.53% | -46.58% |
| 04-25 | Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa | CI |
| 04-15 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Chart calendar Soligenix, Inc.
2c2d6249bfed7.rOsvcifHtlkLv7KGnROOiIKABCKhctrNAkX2hYdvaw0.4bQWJhOvm29u9v2xqlns_en0UkGXKJmGaBOEs9M5HUfpuBwYeIndBk7L9w~b178221f4092e444e0e6f0d4d7982372
Upcoming events on Soligenix, Inc.
Past events on Soligenix, Inc.
| 15/03/2024 11:30 | Q4 2023 Earnings Release |
| 20/02/2024 | RedChip Investor Group Call |
| 29/01/2024 | Microcap Conference |
| 25/01/2024 14:30 | Sequire Investor Summit |
| 15/12/2023 14:00 | Annual General Meeting |
| 13/11/2023 12:30 | Q3 2023 Earnings Release |
| 18/10/2023 | ThinkEquity Conference |
| 21/08/2023 12:30 | Q2 2023 Earnings Release |
| 15/05/2023 12:30 | Q1 2023 Earnings Release |
| 31/03/2023 12:30 | Q4 2022 Earnings Release |
| 08/02/2023 14:00 | Extraordinary Shareholders Meeting |
| 26/01/2023 14:00 | Virtual Investor Summit |
| 05/12/2022 16:00 | RHK Capital Disruptive Growth Conference |
| 14/11/2022 20:00 | FY Investor Summit |
| 10/11/2022 12:30 | Q3 2022 Earnings Release |
| 19/10/2022 14:00 | Annual General Meeting |
| 12/09/2022 12:00 | H.C. Wainwright Global Investment Conference |
| 17/08/2022 14:00 | Emerging Growth Conference |
| 12/08/2022 12:30 | Interim 2022 Earnings Release |
| 24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,60 3,79 21.44% | 2,40 2,20 9.25% | 0,80 0,72 10.42% | 0,90 0,79 13.71% | 0,84 0,80 5.25% | 0,80 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,5 -10,0 -4.9% | -13,6 -14,1 3.69% | -13,1 -12,2 -7.64% | -14,2 -13,9 -2.68% | -7,70 -7,44 -3.47% | -8,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,97 -9,90 -0.65% | -18,5 -15,4 -19.95% | -13,4 -12,4 -8.19% | -15,0 -14,9 -0.36% | -7,91 -7,50 -5.45% | -8,60 |
|
Net income Million USD | Released Forecast Spread | -9,40 -9,29 -1.19% | -17,7 -14,4 -22.86% | -12,6 -12,2 -2.95% | -13,8 -14,0 1.13% | -6,14 -6,35 3.28% | -8,67 |
|
EPS USD | Released Forecast Spread | -7,20 -7,35 2.04% | -9,60 -8,03 -19.63% | -4,65 -4,58 -1.64% | -4,81 -4,80 -0.21% | -0,79 -0,83 4.24% | -0,63 |
| Announcement Date | 30/03/20 | 30/03/21 | 29/03/22 | 31/03/23 | 15/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,25 0,20 25.7% | 0,20 0,10 100% | 0,40 0,20 100% | 0,17 0,20 -16.93% | 0,32 0,20 58.58% | 0,30 0,20 50% | 0,20 0,20 0% | 0,13 0,20 -34.78% | 0,24 0,20 22.41% | 0,20 | 0,20 | 0,20 | 0,20 |
|
EBIT Million USD | Released Forecast Spread | -4,52 -3,60 -25.64% | -4,20 -2,70 -55.65% | -3,40 -3,56 4.59% | -3,08 -3,42 10.01% | -3,57 -3,18 -12.35% | -2,15 -3,50 38.55% | -1,63 -3,01 45.77% | -1,78 -2,89 38.4% | -2,14 -1,86 -14.97% | -2,10 | -2,10 | -2,20 | -2,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,70 -3,70 -27.13% | -4,35 -2,80 -55.32% | -3,54 -3,10 -14.25% | -3,31 -3,30 -0.27% | -3,75 -3,70 -1.45% | -2,21 -3,60 38.69% | -1,61 -3,90 58.67% | -1,66 -4,30 61.33% | -2,43 -2,00 -21.33% | -2,10 | -2,10 | -2,20 | -2,20 |
|
Net income Million USD | Released Forecast Spread | -4,75 -3,69 -28.82% | -4,30 -2,80 -53.57% | -2,40 -3,72 35.41% | -3,31 -3,58 7.61% | -3,76 -3,34 -12.6% | -1,00 -3,60 72.22% | -1,60 -3,16 49.43% | -1,66 -3,10 46.29% | -1,82 -2,02 9.77% | -2,10 | -2,10 | -2,20 | -2,20 |
|
EPS USD | Released Forecast Spread | -1,65 -1,35 -22.22% | -1,50 -1,05 -42.86% | -0,90 -1,28 29.41% | -1,20 -1,35 11.11% | -1,24 -1,13 -10.22% | -0,36 -1,25 71.2% | -0,22 -0,38 42.11% | -0,16 -0,29 44.83% | -0,16 -0,20 17.95% | -0,19 | -0,15 | -0,16 | -0,16 |
| Announcement Date | 29/03/22 | 13/05/22 | 12/08/22 | 10/11/22 | 31/03/23 | 15/05/23 | 21/08/23 | 13/11/23 | 15/03/24 | - | - | - | - |
More events
Past sector events for Soligenix, Inc.
| 03/05/2024 12:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNGX Stock
- Calendar Soligenix, Inc.
